Exclusive

Publication

Byline

US Patent Issued to ARCHER- DANIELS-MIDLAND on May 12 for "Purification of 2,5-furandicarboxylic acid, dimethyl ester and other esterified products" (Illinois Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,013, issued on May 12, was assigned to ARCHER- DANIELS-MIDLAND COMPANY (Decatur, Ill.). "Purification of 2,5-furandicarboxylic acid, dimethy... Read More


US Patent Issued to;Zhejiang Normal University on May 12 for "Fluorescent material containing thiophene sulfone-olefin structural unit and preparation method thereof" (Chinese Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,014, issued on May 12, was assigned to;Zhejiang Normal University (Jinhua, China). "Fluorescent material containing thiophene sulfone-olefin... Read More


US Patent Issued to University of Iowa Research Foundation on May 12 for "JNK inhibitors as anticancer agents" (Iowa, California Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,015, issued on May 12, was assigned to University of Iowa Research Foundation (Iowa City, Iowa). "JNK inhibitors as anticancer agents" was i... Read More


US Patent Issued to GUANGZHOU OCUSUN OPHTHALMIC BIOTECHNOLOGY, OCUSUN OPHTHALMIC PHARMACEUTICAL (GUANGZHOU) on May 12 for "Salt form of isoquinolinone type compound as rock inhibitor and preparation method therefor" (Chinese Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,017, issued on May 12, was assigned to GUANGZHOU OCUSUN OPHTHALMIC BIOTECHNOLOGY Co. LTD. (Guangzhou, China) and OCUSUN OPHTHALMIC PHARMACEUT... Read More


US Patent Issued to Odyssey Therapeutics on May 12 for "Inhibitors of RIPK2 and medical uses thereof" (Michigan, California, Massachusetts Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,018, issued on May 12, was assigned to Odyssey Therapeutics Inc. (Boston). "Inhibitors of RIPK2 and medical uses thereof" was invented by Ch... Read More


US Patent Issued to LEADINGTAC PHARMACEUTICAL (SHAOXING) on May 12 for "Indazole derivative, and preparation method therefor and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,019, issued on May 12, was assigned to LEADINGTAC PHARMACEUTICAL (SHAOXING) Co. LTD. (Zhejiang, China). "Indazole derivative, and preparatio... Read More


US Patent Issued to University of Virginia Patent Foundation on May 12 for "Compositions and methods for preparing and using azetidines" (Virginia Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,020, issued on May 12, was assigned to University of Virginia Patent Foundation (Charlottesville, Va.). "Compositions and methods for prepar... Read More


US Patent Issued to JANSSEN SCIENCES IRELAND UNLtd. on May 12 for "Heterocyclic immunomodulators as PDL1 checkpoint inhibitor" (Belgian Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,022, issued on May 12, was assigned to JANSSEN SCIENCES IRELAND UNLtd. COMPANY (County Cork, Ireland). "Heterocyclic immunomodulators as PDL... Read More


US Patent Issued to NodThera on May 12 for "Sulfonylurea derivatives and uses thereof" (British, American Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,023, issued on May 12, was assigned to NodThera Ltd. (Little Chesterford, Great Britain). "Sulfonylurea derivatives and uses thereof" was in... Read More


US Patent Issued to Reservoir Neuroscience on May 12 for "EP2 antagonist compounds" (California Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,024, issued on May 12, was assigned to Reservoir Neuroscience Inc. (San Francisco). "EP2 antagonist compounds" was invented by Matthew Alexa... Read More